SLC2A1 Gene Paroxysmal Exercise-Induced Dyskinesia with Epilepsy and/or Hemolytic Anemia Genetic Test sale cost 4400 AED
DNAJC6 Gene PARK19 Parkinson Juvenile-Onset Genetic Test sale cost 4400 AED DNAJC6 Gene PARK19 Parkinson Juvenile-Onset Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
EXOSC3 Gene Pontocerebellar Hypoplasia Type 1B Genetic Test sale cost 4400 AED EXOSC3 Gene Pontocerebellar Hypoplasia Type 1B Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SLC2A1 Gene Paroxysmal Exercise-Induced Dyskinesia with Epilepsy and/or Hemolytic Anemia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC2A1 gene is associated with a condition known as paroxysmal exercise-induced dyskinesia (PED), which can sometimes co-occur with epilepsy and/or hemolytic anemia. This condition is characterized by sudden, involuntary movements that are often triggered by prolonged exercise, stress, or fatigue. In some cases, individuals may also experience seizures or an abnormal breakdown of red blood cells, leading to hemolytic anemia.

The genetic test for this condition focuses on identifying mutations in the SLC2A1 gene, which provides instructions for making a protein that transports glucose across the blood-brain barrier. Glucose is the brain’s primary energy source, and disruptions in its transport can lead to neurological symptoms.

DNA Labs UAE offers a comprehensive genetic test for diagnosing mutations in the SLC2A1 gene associated with paroxysmal exercise-induced dyskinesia, epilepsy, and/or hemolytic anemia. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the SLC2A1 gene. This test is crucial for individuals exhibiting symptoms related to these conditions, as it can provide a definitive diagnosis, inform treatment strategies, and guide family planning decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test

At DNA Labs UAE, we offer the SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test at a cost of AED 4400.0.

Test Details:

The SLC2A1 gene is associated with a condition called paroxysmal exercise-induced dyskinesia (PED) with epilepsy and/or hemolytic anemia. This condition is characterized by episodes of abnormal involuntary movements (dyskinesia) triggered by exercise or physical exertion. These episodes may involve the limbs, face, or trunk and can vary in severity and duration.

In addition to dyskinesia, individuals with PED may also experience seizures (epilepsy) and/or hemolytic anemia. Epileptic seizures can manifest as generalized tonic-clonic seizures, absence seizures, or other types of seizures. Hemolytic anemia is a condition characterized by the destruction of red blood cells, leading to a reduced ability of the blood to carry oxygen.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variants that may be associated with a particular condition. In the case of PED with epilepsy and/or hemolytic anemia, NGS genetic testing can be used to identify mutations or variants in the SLC2A1 gene that may be responsible for the condition.

By identifying the specific genetic variant causing PED with epilepsy and/or hemolytic anemia, NGS genetic testing can help in the diagnosis and management of affected individuals. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.

Test Components and Price:

  • Test Name: SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia Genetic Test
  • Price: AED 4400.0

Sample Condition:

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Neurological Disorders

Doctor:

Neurologist

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia.

Test Name SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy andor hemolytic anemia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SLC2A1 Gene Paroxysmal exercise-induced dyskinesia with epilepsy and/or hemolytic anemia
Test Details

The SLC2A1 gene is associated with a condition called paroxysmal exercise-induced dyskinesia (PED) with epilepsy and/or hemolytic anemia. This condition is characterized by episodes of abnormal involuntary movements (dyskinesia) triggered by exercise or physical exertion. These episodes may involve the limbs, face, or trunk and can vary in severity and duration.

In addition to dyskinesia, individuals with PED may also experience seizures (epilepsy) and/or hemolytic anemia. Epileptic seizures can manifest as generalized tonic-clonic seizures, absence seizures, or other types of seizures. Hemolytic anemia is a condition characterized by the destruction of red blood cells, leading to a reduced ability of the blood to carry oxygen.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variants that may be associated with a particular condition. In the case of PED with epilepsy and/or hemolytic anemia, NGS genetic testing can be used to identify mutations or variants in the SLC2A1 gene that may be responsible for the condition.

By identifying the specific genetic variant causing PED with epilepsy and/or hemolytic anemia, NGS genetic testing can help in the diagnosis and management of affected individuals. It can also provide information about the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.

SKU: TEST-1898